SPIN-SSLED项目部分嵌套随机对照试验方案
针对系统性硬化症患者支持小组领导者,SPIN-SSLED试验采用部分嵌套随机对照设计,将180名领导者随机分入培训组(每组6人)或等待名单对照,评估13模块网络培训对领导者自我效能的影响。主要结局为干预后自我效能,次要结局包括倦怠、满意度和情绪困扰。
要点
- 培训组接受每周1次、每次60-90分钟、共3个月的13模块网络培训。
- 主要结局为干预后支持小组领导者自我效能,采用专用量表测量。
- 部分嵌套设计反映培训组内个体间的依赖性,等待名单对照无此依赖。
核心结论
- SPIN-SSLED试验将检验培训项目能否提高SSc患者支持小组领导者的自我效能。
研究设计与样本
- 实用随机对照试验,采用部分嵌套设计,180名支持小组领导者随机分入培训组(每组6人)或等待名单对照。
- 培训组接受13模块SPIN-SSLED项目,通过网络研讨会每周1次、每次60-90分钟、持续3个月。
主要发现
- 此前可行性试验中,项目成功 delivered 给两组支持小组领导者,领导者对项目及实施满意度高。
关键数值与推荐
- 主要结局为干预后领导者自我效能,采用硬皮病支持小组领导者自我效能量表测量。
- 次要结局包括干预后及干预后3个月的领导者自我效能、倦怠、志愿工作满意度(参与效能)和情绪困扰。
临床怎么用
- 若有效,该项目可能改善现有SSc支持小组的有效性和可持续性,增加可用支持小组数量,并可适配其他慢性病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some people with rare diseases rely on peer-led support groups for disease-specific education and emotional and practical support. Systemic sclerosis (SSc), or scleroderma, is a rare autoimmune connective tissue disease. Many people with SSc cannot access support groups, and, when support groups exist, they may not be sustained due to challenges that could be addressed via leader training. The Scleroderma Patient-centered Intervention Network (SPIN), along with SSc patient organization partners, developed a training program for SSc patient support group leaders, the Scleroderma Support group Leader EDucation (SPIN-SSLED) Program. We recently completed a feasibility trial in which we successfully delivered the program to two groups of support group leaders who reported a high level of satisfaction with the program and its delivery. The primary objective of the full-scale SPIN-SSLED trial is to evaluate the effect of the program on support group leaders' self-efficacy for carrying out their leadership role. Secondary objectives include evaluating effects on leader burnout, leader satisfaction (participation efficacy), and emotional distress. METHODS/DESIGN: The SPIN-SSLED trial is a pragmatic randomized controlled trial (RCT) in which 180 support group leaders will be randomly allocated to training groups of 6 participants each or to a waitlist control. We will use a partially nested RCT design to reflect dependence between individuals in training groups, but not in the waitlist control. Participants allocated to the training program will receive the 13-module SPIN-SSLED Program, delivered via webinar over the course of 3 months in weekly 60-90-min sessions. The primary outcome is leader self-efficacy, measured by the Scleroderma Support Group Leader Self-efficacy Scale post-intervention. Secondary outcomes are leader self-efficacy at 3 months post-intervention, and leader burnout, volunteer job satisfaction (participation efficacy), and emotional distress post-intervention and at 3 months post-intervention. DISCUSSION: The SPIN-SSLED trial will test whether a training program for SSc patient support group leaders increases the self-efficacy of group leaders to carry out leadership tasks. The program has the potential to significantly improve the effectiveness and sustainability of existing SSc support groups, to increase the number of available support groups, and to be adapted for other chronic diseases. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03965780. Registered on 29 May 2019.
引用
- Thombs BD, Aguila K, Dyas L, et al. Protocol for a partially nested randomized controlled trial to evaluate the effectiveness of the Scleroderma Patient-centered Intervention Network Support Group Leader EDucation (SPIN-SSLED) Program. Trials. 2019. PMID: 31831073. doi:10.1186/s13063-019-3747-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。